COSMOS Pharmaceutical Corporation (TYO:3349)
Japan · Delayed Price · Currency is JPY 6,383.00
-497.00 (-7.22%)
Jul 31, 2026, 3:30 PM JST
COSMOS Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
| 505,899 | 476,495 | 700,001 | 502,890 | 525,081 | 483,107 | |
Market Cap Growth | -30.96% | -31.93% | 39.20% | -4.23% | 8.69% | -19.89% |
Enterprise Value | 523,034 | 496,369 | 705,765 | 495,143 | 507,058 | 456,292 |
Last Close Price | 6383.00 | 6012.00 | 8722.06 | 6211.88 | 6435.62 | 5878.54 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
PE Ratio | 15.79 | 14.87 | 22.60 | 20.57 | 22.07 | 20.86 |
Forward PE | 15.68 | 14.54 | 21.94 | 19.07 | 21.97 | 19.33 |
PS Ratio | 0.46 | 0.43 | 0.69 | 0.52 | 0.63 | 0.64 |
PB Ratio | 1.78 | 1.68 | 2.72 | 2.17 | 2.49 | 2.54 |
P/TBV Ratio | 1.79 | 1.69 | 2.72 | 2.18 | 2.49 | 2.54 |
P/FCF Ratio | - | - | - | - | 67.33 | - |
P/OCF Ratio | 8.61 | 8.11 | 13.34 | 9.11 | 9.65 | 15.01 |
PEG Ratio | 3.20 | 2.50 | 2.26 | 2.90 | 5.05 | 4.03 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
EV/Sales Ratio | 0.48 | 0.45 | 0.70 | 0.51 | 0.61 | 0.60 |
EV/EBITDA Ratio | 7.87 | 7.47 | 11.27 | 9.63 | 10.68 | 10.16 |
EV/EBIT Ratio | 12.48 | 11.85 | 17.47 | 15.72 | 16.83 | 15.31 |
EV/FCF Ratio | - | - | - | - | 65.02 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Debt / Equity Ratio | 0.28 | 0.28 | 0.19 | 0.15 | 0.09 | 0.05 |
Debt / EBITDA Ratio | 1.18 | 1.18 | 0.80 | 0.66 | 0.38 | 0.21 |
Debt / FCF Ratio | - | - | - | - | 2.33 | - |
Net Debt / Equity Ratio | 0.06 | 0.06 | -0.03 | -0.08 | -0.13 | -0.15 |
Net Debt / EBITDA Ratio | 0.26 | 0.26 | -0.11 | -0.35 | -0.58 | -0.62 |
Net Debt / FCF Ratio | -1.47 | -1.47 | 8.24 | 28.72 | -3.56 | 2.47 |
Asset Turnover | 1.96 | 1.96 | 2.02 | 2.15 | 2.11 | 2.15 |
Inventory Turnover | 9.09 | 9.09 | 8.94 | 9.49 | 9.16 | 9.52 |
Quick Ratio | 0.34 | 0.34 | 0.31 | 0.30 | 0.29 | 0.28 |
Current Ratio | 0.77 | 0.77 | 0.75 | 0.72 | 0.71 | 0.71 |
Return on Equity (ROE) | 11.84% | 11.84% | 12.67% | 11.05% | 11.85% | 12.83% |
Return on Assets (ROA) | 4.67% | 4.67% | 5.04% | 4.39% | 4.80% | 5.29% |
Return on Invested Capital (ROIC) | 10.21% | 11.02% | 12.74% | 11.52% | 12.65% | 14.47% |
Return on Capital Employed (ROCE) | 11.80% | 11.80% | 13.30% | 12.00% | 13.20% | 14.80% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Earnings Yield | 6.33% | 6.73% | 4.42% | 4.86% | 4.53% | 4.79% |
FCF Yield | -2.31% | -2.45% | -0.12% | -0.13% | 1.49% | -2.34% |
Dividend Yield | 1.32% | 1.36% | 0.80% | 0.97% | 0.78% | 0.68% |
Payout Ratio | 20.28% | 18.54% | 16.01% | 19.05% | 13.72% | 14.11% |
Buyback Yield / Dilution | - | 0.00% | -0.02% | -0.05% | 0.00% | 0.00% |
Total Shareholder Return | 1.32% | 1.36% | 0.78% | 0.91% | 0.78% | 0.68% |